Transdiagnostic Internet-delivered REBT Intervention for Adolescents' Internalizing Problems (REBTonAd)

September 12, 2023 updated by: Anca Dobrean, Babes-Bolyai University

The Efficacy and Mechanisms of Change of a Transdiagnostic Internet-delivered REBT Intervention for Adolescents With Internalizing Problems: A Randomized Controlled Trial

To investigate the efficacy and mechanisms of change of an Internet-delivered transdiagnostic REBT intervention for adolescents with internalizing problems.

Study Overview

Detailed Description

The main objectives of this study are to evaluate the efficacy and mechanisms of change of an Internet-delivered Rational Emotive Behavior Therapy for adolescents (12-15 years) diagnosed with a principal anxiety or depressive disorder according to DSM-5 criteria. Participants will be randomly allocated to one of the two groups: experimental (REBTonAd) and waitlist control. The intervention is structured in 8 modules and will be delivered over six weeks. Assessments will be conducted at four time points: baseline, post-treatment, 3-month follow-up, and 6-month follow-up.

Study Type

Interventional

Enrollment (Actual)

106

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cluj
      • Cluj-Napoca, Cluj, Romania, 400015
        • Babes-Bolyai University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 15 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age between 12 and 15 years
  • A principal diagnosis of Social Anxiety Disorder, Generalized Anxiety Disorder, Panic Disorder, Persistent Depressive Disorder, or Major Depressive Disorder as defined by DSM-5 (APA, 2013)
  • Not currently following another treatment (psychotherapy, pharmacological treatment);
  • Internet access
  • Ability to read and write Romanian

Exclusion Criteria:

  • Suicidal ideation
  • Severe depression
  • Any physical and mental health acute problem that requires hospitalization
  • Diagnosed with autism spectrum disorder, psychosis, bipolar disorder or mental disability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Transdiagnostic Internet-delivered REBT
Protocol is based on Rational Emotive Therapy (Ellis, 1962, 1994), structured in 8 modules delivered over 6 weeks (Module 1- Introduction and psychoeducation about emotions, Module 2 - Psychoeducation anxiety and depression, Module 3 - Relaxation, Module 4 - Negative patterns of thinking and cognitive restructuring, Module 5 - Problem solving, Module 6 - Exposure and Behavioral activation, Module 7 - Positive emotions and Module 8 - Gaining maintenance)
The protocol is based on Rational Emotive and Behavioral Therapy (REBT; Ellis, 1962, 1994). The program will consist of 8 modules, delivered online over six weeks.
No Intervention: Waitlist
Participants in the control group will complete pre-treatment and post-treatment assessments. After participants in the experimental group complete post-treatment assessment, they will receive the intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Internalizing problems measured with the Youth Self-Report 11/18 (YSR; Achenbach & Rescorla, 2001)
Time Frame: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
Change in self-reported internalizing problems from baseline to post-treatment, at 6 months post treatment. Higher scores indicate higher levels of internalizing problems.
Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Automatic Thoughts QuestionnaireShort Version (ATQ-SV; Netemeyer et al., 2002)
Time Frame: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
Change in negative automatic thoughts from baseline. Higher scores indicating higher levels of negative automatic thoughts.
Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
The child and adolescent scale of irrationality (CASI; Bernard & Cronan, 1999)
Time Frame: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
Change in irrational beliefs from baseline. Higher scores indicate higher levels of irrational beliefs.
Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
The Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents, The Revised Version - adolescent version (Kiddo-KINDL; Ravens-Sieberer, & Bullinger, 1998)
Time Frame: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
Change in quality of life from baseline from baseline. Higher scores indicate higher levels of quality of life.
Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
The Adolescent Peer Relations Instrument (APRI; Parada, 2000)
Time Frame: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
Change in bullying victimization from baseline. Higher scores indicate higher levels of peer victimization.
Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
Principal diagnosis based on Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria
Time Frame: Baseline, 6-month follow-up
Diagnostic interview for anxiety disorders and/or depressive disorders
Baseline, 6-month follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
The anxiety subscale from The Beck Youth Inventories™ -Second Edition for Children and Adolescents (Beck, Beck, & Jolly, 2005).
Time Frame: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
Change in anxiety subscale from baseline. This subscale contains 20 items, rated on a 4 point Likert scale, with 0 = Never and 3 = Always. The total score is obtained by summing the 20 items, with higher scores indicating higher symptoms of anxiety.
Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
The depression subscale from the Beck Youth Inventories™ -Second Edition for Children and Adolescents (Beck et al., 2005)
Time Frame: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
Change in depression subscale from baseline. This subscale contains 20 items, rated on a 4 point Likert scale, with 0 = Never and 3 = Always. The total score is obtained by summing the 20 items, with higher scores indicating higher symptoms of depression.
Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
Client Satisfaction Scale
Time Frame: Immediately after the intervention (an expected average of 6 weeks)
Satisfaction with the program. Higher scores indicate higher treatment satisfaction
Immediately after the intervention (an expected average of 6 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anca Dobrean, Ph.D., Babes-Bolyai University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 25, 2020

Primary Completion (Actual)

May 30, 2022

Study Completion (Actual)

December 30, 2022

Study Registration Dates

First Submitted

November 14, 2019

First Submitted That Met QC Criteria

November 26, 2019

First Posted (Actual)

November 27, 2019

Study Record Updates

Last Update Posted (Actual)

September 13, 2023

Last Update Submitted That Met QC Criteria

September 12, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety Disorders

Clinical Trials on Transdiagnostic Internet-delivered REBT

Subscribe